ImmunityBio, Inc.IBRXNASDAQ
Loading
Cash generated from core business operations
Latest
$-304.94M
↓ 42% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-214.94M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-304.94M | +22.1% |
| 2024 | $-391.24M | -6.7% |
| 2023 | $-366.76M | -8.7% |
| 2022 | $-337.51M | -23.0% |
| 2021 | $-274.42M | -59.8% |
| 2020 | $-171.72M | -12.9% |
| 2019 | $-152.11M | -140.0% |
| 2018 | $-63.38M | -29.9% |
| 2017 | $-48.78M | -26.4% |
| 2016 | $-38.59M | - |